Search
Mostrar filtros
Add filters:
Use filters to refine the search results.
Results 1-8 of 8 (Search time: 0.005 seconds).
| Issue Date | Title | Author(s) |
|---|---|---|
| 2013 | Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features | BARROSO-SOUSA, Romualdo; MUNHOZ, Rodrigo Ramella; FONSECA, Leonardo Gomes; FEDE, Angelo Bezerra de Sousa; LINCK, Rudinei Diogo Marques; MONIZ, Camila Motta Venchiarutti; MAK, Milena Perez; SOUZA, Ciro Eduardo; HOFF, Paulo M.; DZIK, Carlos |
| 2013 | Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)? | MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel |
| 2013 | Prognostic value of early objective tumor response (EOTR) to first-line systemic therapy in metastatic colorectal cancer (mCRC): Individual patient data (IPD) meta-analysis of randomized trials from the ARCAD database. | SOMMEIJER, Dirkje Willemien; SHI, Qian; MEYERS, Jeffrey P.; SJOQUIST, Katrin Marie; HOFF, Paulo Marcelo; SEYMOUR, Matthew T.; CASSIDY, James; GOLDBERG, Richard M.; DOUILLARD, Jean-Yves; HECHT, J. Randolph; HURWITZ, Herbert; TOURNIGAND, Christophe; TEBBUTT, Niall C.; ARANDA, Enrique; SOUGLAKOS, John; KABBINAVAR, Fairooz F.; CHIBAUDEL, Benoist; GRAMONT, Aimery De; SARGENT, Daniel J.; ZALCBERG, John Raymond |
| 2013 | Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2 positive advanced or metastatic gastric (A/MGC), esophageal (EAC), or gastroesophageal (GEJ) adenocarcinoma: The LOGiC trial. | HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J. |
| 2013 | Lapatinib in combination with capecitabine plus oxaliplatin (CapeOx) in HER2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma (AC): The TRIO-013/LOGiC Trial. | HECHT, J. Randolph; BANG, Yung-Jue; QIN, Shukui; CHUNG, Hyun-Chul; XU, Jian-Ming; PARK, Joon Oh; JEZIORSKI, Krzysztof; SHPARYK, Yaroslav; HOFF, Paulo M.; SOBRERO, Alberto F.; SALMAN, Pamela; LI, Jin; PROTSENKO, Svetlana; BUYSE, Marc E.; AFENJAR, Karen; KANEKO, Tomomi; KEMNER, Allison; SANTILLANA, Sergio; PRESS, Michael F.; SLAMON, Dennis J. |
| 2013 | Pertuzumab (P) with trastuzumab (T) and chemotherapy (CTX) in patients (pts) with HER2-positive metastatic gastric or gastroesophageal junction (GEJ) cancer: An international phase III study (JACOB) | TABERNERO, Josep; HOFF, Paulo Marcelo; SHEN, Lin; OHTSU, Atsushi; YU, Ron; ENG-WONG, Jennifer; KANG, Yoon-Koo |
| 2013 | Cancer patients with ECOG-PS higher than 1: Who are those who benefit of palliative chemotherapy? | CAIRES-LIMA, Rafael; PROTASIO, Bruno Mendonca; CAIRES, Inacelli Queiroz de Souza; ROCHA, Lucila Soares Da Silva; OLIVEIRA, Julia Andrade De; GUERRA, Raquel Bezerra; MAK, Milena Perez; HOFF, Paulo M.; CASTRO, Gilberto |
| 2013 | Clinical characteristics at diagnosis of patients who survive more than 5 years after diagnosis of metastatic colorectal cancer (mCRC). | ABRAHAO, Manuel Cruz; SANTOS, Joao Paulo Velloso Medrado; PAVAN, Thayse; HOFF, Paulo M.; KATZ, Artur; SABBAGA, Jorge; AZEVEDO, Fernanda; FREITAS, Daniel; SARAGIOTTO, Daniel F.; COSTA, Frederico |
- previous
- 1
- next